|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Intestinal barrier dysfunction in cirrhosis: Current concepts in pathophysiology and clinical implications显示文摘The intestinal lumen is a host place for a wide range of microbiota and sets a unique interplay between local immune system, inflammatory cells and intestinal epithelium, forming a physical barrier against microbial invaders and toxins. Bacterial translocation is the migration of viable or nonviable microorganisms or their pathogen-associated molecular patterns, such as lipopolysaccharide, from the gut lumen to the mesenteric lymph nodes, systemic circulation and other normally sterile extraintestinal sites. A series of studies have shown that translocation of bacteria and their products across the intestinal barrier is a commonplace in patients with liver disease. The deterioration of intestinal barrier integrity and the consulting increased intestinal permeability in cirrhotic patients play a pivotal pathophysiological role in the development of severe complications as high rate of infections, spontaneous bacterial peritonitis, hepatic encephalopathy, hepatorenal syndrome, variceal bleeding, progression of liver injury and hepatocellular carcinoma. Nevertheless, the exact cellular and molecular mechanisms implicated in the phenomenon of microbial translocation in liver cirrhosis have not been fully elucidated yet. | Georgios I Tsiaoussis Stelios F Assimakopoulos Athanassios C Tsamandas Christos K Triantos Konstantinos C Thomopoulos | 2015 | World Journal of Hepatology2015，7，17： | 4 |
| 2 | 化疗栓塞联合其他方法治疗肝细胞癌的评价显示文摘 引言
肝癌是世界上第5 种最常见的肿瘤且其发病率仍在上升.在欧洲,80%的肝细胞癌(HCC)并发于肝硬化且是其主要死因.
虽然公布了一些方案,但对HCC 病人的常规治疗策略并没有取得世界范围内的统一.巴塞罗那临床肝癌(BCLC)分类和治疗方案于最近公布.按照该方案,放疗[包括切除、肝移植、经皮消融(经皮乙醇注射以及射频)]可以运用于30%~40%的HCC 病人,而另外更多的病人则需要采用其他的手段.…… | Marelli L Stigliano R Triantos C 刘军麟 | 2007 | 中华普通外科学文献(电子版)2007，1，3： | 3 |
| 3 | A rare etiology of post-endoscopic retrograde cholangiopancreatography pneumoperitoneum显示文摘Major complications of endoscopic retrograde cholangiopancreatography (ERCP) include pancreatitis, hemorrhage, cholangitis, and duodenal perforation. The occurrence of free air in the peritoneal cavity post- ERCP is a rare event (< 1%), which is usually the result of duodenal or ductal perforation related to therapeutic ERCP with sphincterotomy. We describe for the first time a different aetiology of pneumoperitoneum, in an 84-year-old woman with pancreatic cancer and a large hepatic metastasis, after ERCP with common bile duct stent deployment. Our patient developed, pneumoperitoneum due to air leakage from rupture of intrahepatic bile ducts and Glisson’s capsule in the area of a peripheral large hepatic metastasis. The potential mechanism underlying this complication might be post- ERCP pneumobilia and increased pressure of intrahepatic bile ducts leading to rupture of intrahepatic bile ducts in the liver metastatic mass owing to neoplastic tissue friability. This case indicates the need for close clinical and radiological observation of patients with hepatic masses (primary or metastatic) subjected to ERCP. In such patients, avoidance of excessive air insufflation during ERCP and/or placement of a nasogastric tube for bowel decompression immediately after ERCP might be a reasonable strategy to prevent such unusual complications. | Stelios F Assimakopoulos Konstantinos C Thomopoulos Sofia Giali Christos Triantos Dimitrios Siagris Charalambos Gogos | 2008 | World Journal of Gastroenterology2008，14，18： | 2 |
| 4 | Management of varices inpatients with cirrhosis 显示文摘 | QBrien J Triantos C Burroughs AK | 2013 | Nat Rev Gastroenterol Hepatol2013，10，7： | 1 |
| 5 | Antiviral therapy reduces portal pressure in patients with cirrhosis due to HBeAg -negative chronic hepatitis B and significant portal hypertension 显示文摘 | MANOLAKOPOULOS S TRIANTOS C THEODOROPOULOS J | 2009 | J Hepatol2009，51，3： | 1 |
| 6 | Transarterial therapy for hepatocellular carcinoma:which technique is more effec- tive? A systematic review of cohort and randomized studies 显示文摘 | Marelli L Stigliano R Triantos C | 2007 | Cardiovasc Intervent Radiol2007，30，： | 1 |
| 7 | Treatment outcomes for hepatocellular carcinoma using chemoembolization in combination with other therapies 显示文摘 | Marelli L Stigliano R Triantos C | 2006 | Cancer Trea Rev2006，32，8： | 1 |
| 8 | Clinical trial:The effect of somatostatin vs oetreotide in preventing post-endoscopicincrease in hepatic venous pressure gradient in cirrhotics with bleed-ing varices显示文摘 | Vlachogiannakos J Kougioumtzian A Triantos C | 2007 | Aliment Pharmacol Ther2007，26，12： | 1 |
| 9 | Meta - analysis: antiviral treatment for hepatitis D 显示文摘 | TRIANTOS C KALAFATELI M NIKOLOPOULOU V | 2012 | Ali- ment Pharmacol Ther2012，35，6： | 1 |
| 10 | Management of varices in patients with cirrhosis 显示文摘 | O'Brien J Triantos C Burroughs AK | 2013 | Nat Rev Gastroenterol Hepatol2013，10，7： | 1 |
| 11 | Clinical trial: The effect of somatostatin versus octreotide in preventing the post-endoscopic increase of HVPG in cirrhotics with bleeding varices显示文摘 | Vlachogiannakos J Kougioumtzian A Triantos C | 2007 | Aliment Pharmacol Ther2007，26，1112： | 1 |
| 12 | Liver transplantation and hepatitis C virus: systematic review of antiviral therapy显示文摘 | Triantos C Samonakis D Stigliano R | 2005 | Transplantation2005，79，3： | 1 |
| 13 | Transarterial therapy for hepatocellular carcinoma: which technique is more effective? A systematic review of cohort and randomized studies 显示文摘 | Marelli L Stigliano R Triantos C | 2007 | Cardiovase Intervent Radiol2007，30，： | 1 |
| 14 | Transarterial therapy for hepatoeellular carcinoma: which technique is more effective? A systematic review of cohort and randomized studies显示文摘 | Marelli L Stigliano R Triantos C | 2007 | Cardiovase Intervent Radiol2007，30，1： | 1 |
| 15 | Antiviral therapy reduces portal pressure in patients with cirrhosis due to HBeAg - negative chronic hepatitis B and significant portal Hypertension 显示文摘 | Manol akopoulos S Triantos C Theodoropoulos J | 2009 | J Hepatol2009，，51： | 1 |
| 16 | Transarterial therapy for hepatocellular carcinoma:which technique is more effective?A systematic review of cohort and randomized studies显示文摘 | Marelli L Stigliano R Triantos C | 2007 | Cardiovasc Inter vent Radiol2007，30，： | 1 |
| 17 | Monolobar Caroli's disease complicate by eholangiocarcinoma in a 70 - year - old man, previously asymptomatic 显示文摘 | Vlachogiannakos J Potamianos S Triantos C | 2004 | Gastrointestinal Endoscopy2004，60，2： | 1 |
| 18 | Transarterial therapy for hepatocellular car- cinoma: Which technique is more effective? A systematic review of cohort and random- ized studies 显示文摘 | Marelli L Stigliano R Triantos C | 2007 | Cardiovascular and inter- ventional radiology2007，30，1： | 1 |
| 19 | octreotide in preventing post- endoscopic increase in hepatic venous pressure gradient in cirrhosis with bleeding varices 显示文摘 | Vlaehogiannakos J Kougioumtzian A Triantos C et ah Clinical trial: The effect of somatostatin vs | 2007 | Aliment Pharmacol Ther2007，26，1112： | 1 |
| 20 | Abnormal liver function tests in a patient with myotonic dystrophy type 1显示文摘 | Kalafateli M Triantos C Tsamandas A | 2012 | Ann Hepatol2012，11，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员